Maom Lab @ UMich

We a computational pharmacology group in the Department of Computational Medicine and Bioinformatics at the Univerersity of Michigan in Ann Arbor, Michigan. We use computational and statistical modeling to develop chemical probes.

In science models are used to simulate the behavior of intractable systems that we want to understand. For example, cell-culture may be use to model an organisms response to drugs.

model building paradigm

In our group, we do two types of modeling. First we use molecular simulations and deep neural networks to represent how molecules and chemicals interact. While computational models are can be quite realistic, often they are intractable and difficult to compare with biochemical and phenotypic measurements. So, second we use statistical models to facilitate summarizing experimental data and making inferences.

We are fortunate to collaborate with a range of exciting experimental labs, where we work closely with them to analyze the data and plan new experiments.

News

Nov 16 2026

Manasa and Miguel gave invited oral presentations at the ACS Midwest Regional Meeting at Kansas State University.

Oct 10 2026

Annika will be joining us in 2027 as a PhD student! Congrats, Annika!

Oct 01 2026

Welcome to our newest undergraduate lab members! Sally joins us through MRADS, and Jackson joins as a UROP student. Sally will be working with Manasa, and Jackson will be working with John on their major projects.

Sep 2026

Weiyang is continuing in the lab as a PhD student. Congrats, Weiyang!

Sep 18 2026

The DCMB Annual Retreat was a blast! Manasa and John both presented posters. Congrats to both!

Sep 11 2026

John presented a poster at the AI & Health Symposium at the University of Michigan.

Aug 31 2026

Hani has transitioned to working on an MS in Bioinformatics. Congrats, Hani!

Aug 06 2026

Manasa gave an oral presentation at RosettaCon Summer 2026 in Seattle, WA.

Jul 2026

Corleigh is leaving the lab to start a Master’s program at the University of Pittsburgh. We’ll miss you, and best of luck!

... see all News